Alveo Technologies is a San Francisco-based company that makes affordable and accessible infectious disease diagnostic devices. Led by founder and CEO Ron Chiarello, PhD, the company is pre-clinical and developing a rapid diagnostic platform for infectious diseases. Alveo intends to use the recent funding to advance optimization and commercialization of its rapid diagnostic platform. The company describes its work as creating a new ecosystem for the detection of diseases. Financially, Alveo closed a $38M Series A financing to support those development and commercialization efforts.

Total raised

$38M

Funding rounds

1

Latest round

Series A

Latest activity

Jan 2018